ASLAN Pharmaceuticals (ASLN) Announces Filing for Proposed ADS IPO

ASLAN Pharmaceuticals (NASDAQ: ASLN) today announced that it has filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of its American Depository Shares (ADSs) in the United States.

ASLAN has applied to list its ADSs on The Nasdaq Global Market under the trading symbol “ASLN”. All ADSs to be sold in the offering will be offered by ASLAN. The number of ADSs to be offered, and the price range for the proposed offering have not yet been determined.

Leerink Partners and Piper Jaffray & Co. are acting as joint book-running managers for this offering. BTIG, H.C. Wainwright & Co. and CLSA Limited are acting as co-managers for this offering.

You May Also Be Interested In

• INNIO prices upsized IPO at $27 per share on nasdaq
• SINTX Technologies raises $5 million through private placement
• 3D Systems announces $40 million public stock offering